Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Glucagon receptor agonism increases hepatic glucose output and is hypothesised to promote lipolysis and increase energy expenditure, though the magnitude of this effect in humans is uncertain and context-dependent
10.3389/fonc.2018.00549 Front Oncol
Studies have shown that the injectable version can reduce HbA1c by up to 2.3% , which is a significant improvement for people with type 2 diabetes
An 80mg KLOW vial reconstituted with 4mL of bacteriostatic water yields 20mg/mL
Expect modest changesnot a dramatic fat loss effect
doi: 10.1002/dmrr.v26:4 11 HolstJJ
US$ 21.96
US$ 23.46
US$ 22.65
